Lung Inflammation in Health and Disease, Volume II
Lung diseases are leading causes of death and disability globally, with about 65 million people suffering from COPD, and 334 million from asthma. Each year, tens of millions of people develop and can die from lung infections such as pneumonia and TB. Systemic inflammation may induce and exacerbate l...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham
Springer International Publishing
2021, 2021
|
| Edition: | 1st ed. 2021 |
| Series: | Advances in Experimental Medicine and Biology
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- 1. Can GPCRs be targeted to control inflammation in asthma?
- 2. Cellular and molecular processes in pulmonary hypertension
- 3. INFLAMMATORY PATHWAYS IN SARCOIDOSIS
- 4. Innate Immune Responses and Pulmonary Diseases
- 5. Interstitial Lung Disease associated with Connective Tissue Diseases
- 6. Molecular mechanisms of vascular damage during lung injury
- 7. Neurotrophin Regulation and Signaling in Airway Smooth Muscle
- 8. Novel Thoracic MRI approaches for the assessment of pulmonary physiology and inflammation
- 9. Overview on Interactive Role of Inflammation, Reactive Oxygen Species and Calcium signaling in Asthma, COPD and Pulmonary Hypertension
- 10. Protein S-palmitoylation and lung diseases
- 11. Redox role of ROS and inflammation in pulmonary diseases
- 12. Semaphorin3E/PlexinD1 axis in asthma: what we know so far
- 13. Serine protease inhibitors to treat lung inflammatory diseases
- 14. Sex and Gender Differences in Lung Disease
- 15. Sex hormones and lung inflammation
- 16. Synopsis of Clinical Acute Respiratory Distress Syndrome (ARDS)